Detalhe da pesquisa
1.
Evaluation of genetic variants associated with the risk of thiopurine-related pancreatitis: a case control study from ENEIDA registry.
Dig Dis
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38452742
2.
Increased risk of MAFLD and Liver Fibrosis in Inflammatory Bowel Disease Independent of Classic Metabolic Risk Factors.
Clin Gastroenterol Hepatol
; 21(2): 406-414.e7, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124272
3.
Consequences and management of COVID-19 on the care activity of an Inflammatory Bowel Disease Unit.
Rev Esp Enferm Dig
; 113(2): 98-102, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33342217
4.
Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
Gut
; 67(1): 70-78, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27612488
5.
Development of quality standards in inflammatory bowel disease management and design of an evaluation tool of nursing care.
Rev Esp Enferm Dig
; 105(5): 262-71, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23971657
6.
Differentially Deregulated MicroRNAs as Novel Biomarkers for Neoplastic Progression in Ulcerative Colitis.
Clin Transl Gastroenterol
; 13(7): e00489, 2022 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35404333
7.
Qualitative study on WIC Program strategies to promote breastfeeding practices in Puerto Rico: what do nutritionist/dietician's think?
Matern Child Health J
; 15(4): 520-6, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20221847
8.
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experience.
Gastroenterol Hepatol
; 34(7): 443-8, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21724297
9.
[Markers of the course of inflammatory bowel disease treated with immunomodulators or biological agents]. / Marcadores de evolución de la enfermedad inflamatoria intestinal tratada con inmunomoduladores o agentes biológicos.
Gastroenterol Hepatol
; 33(6): 449-60, 2010.
Artigo
em Espanhol
| MEDLINE | ID: mdl-20122758
10.
Visceral leishmaniasis as an unusual infectious complication in a patient with Crohn's disease treated with infliximab.
Gastroenterol Hepatol
; 38(6): 411-2, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25443540
11.
Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.
Inflamm Bowel Dis
; 26(4): 606-616, 2020 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504569
12.
Timing of Thiopurine or Anti-TNF Initiation Is Associated with the Risk of Major Abdominal Surgery in Crohn's Disease: A Retrospective Cohort Study.
J Crohns Colitis
; 10(1): 55-60, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26520164
13.
Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease: a pilot study.
Inflamm Bowel Dis
; 11(1): 8-15, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15674108
14.
Nursing resources and responsibilities according to hospital organizational model for management of inflammatory bowel disease in Spain.
J Crohns Colitis
; 5(3): 211-7, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21575883
15.
Contribution of nurses to the quality of care in management of inflammatory bowel disease: a synthesis of the evidence.
J Crohns Colitis
; 4(6): 611-22, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21122570
16.
Ethical issues in nutritional sciences for the next century: nutrition research and counseling of nutraceutical supplementation and disease
P. R. health sci. j
; 19(2): 161-3, Jun. 2000.
Artigo
em Inglês
| LILACS | ID: lil-268461